13 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2038. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2038
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Jan 2039 · High confidence
Also notable
Ends no later than Jan 2045 · Low confidence
Reporting Syringe
US 11,324,887
A family of 53 related applications built on the 2022 grant. Protection runs to 2039.
Injectable Administration Compliance Platform
US 12,746,347
A family of 9 related applications built on the 2026 grant. Too new for citation comparison; protection runs to 2045. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
- 9 of the patents on this record were granted since Aug 16, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Reporting Syringe | 12 in force | to Jan 2045 |
| Injectable Administration Compliance Platform | 1 in force | to Jan 2045 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,409,269 | Tracking Medication Usage and Supply Chain Event Using Networked Intelligent Injection Devices In force · High confidence | In force | High confidence | |
| US 12,415,034 | Medical Waste Management Using an Intelligent Injection Device In force · High confidence | In force | High confidence | |
| US 12,741,091 | Intelligent Injection Device Platform Using Governance Rules In force · High confidence | In force | High confidence | |
| US 12,752,054 | Dosage Management and Patient Education Using an Intelligent Injection Device In force · High confidence | In force | High confidence | |
| US 12,752,055 | Intelligent Dosing Platform System with Prior Authorization and Pharmacy Benefit Manager Integration In force · High confidence | In force | High confidence | |
| US 12,766,256 | Longitudinal Health Outcome Monitoring Using an Intelligent Injection Device Platform In force · High confidence | In force | High confidence | |
| US 12,766,257 | Artificial Intelligence Patient Guidance System for Injectable Medication Administration In force · High confidence | In force | High confidence | |
| US 12,779,115 | Multi-Compound and Custom Dosing Using an Intelligent Injection Device Platform In force · High confidence | In force | High confidence | |
| US 11,324,887 | Reporting Syringe In force · High confidence | In force | High confidence | |
| US 12,758,710 | Reporting Syringe In force · High confidence | In force | High confidence |
Also on record, not counted in the 13: 47 applications pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed
2 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.